https://www.selleckchem.com/products/crcd2.html
9 and 24.4 more LYG, respectively. With perfect adherence, screening initiation at age 45 versus 50years resulted in 26.1 and 28.6 CRC cases, respectively, with mt-sDNA and 22.8 and 25.5 cases with FIT; with reported real-world adherence there were 28.5 and 31.2 cases, respectively, with mt-sDNA and 37.1 and 40.2 cases with FIT. Similar patterns were observed for CRC deaths. With screening initiation at age 45 and reported adherence, mt-sDNA averted 8.6 more CRC cases and 3.3 more deaths per 1000 individuals than FIT. Estimated CRC screen
Like
Comment
Share
